Bogdan Mitran

1.6k citations

55 papers · 1.3k indexed · h-index 25

Impact in

Radiology, Nuclear Medicine and Imaging top 1%
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
Oncology top 5%
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 49
- Radiopharmaceutical Chemistry and Applications 40
- Monoclonal and Polyclonal Antibodies Research 35
- Medical Imaging Techniques and Applications 4
Oncology 32
- HER2/EGFR in Cancer Research 16
- Peptidase Inhibition and Analysis 10

Co-authors: Anna Orlova (48 shared papers)Vladimir Tolmachev (48 shared papers)John Löfblom (23 shared papers)Mohamed Altai (15 shared papers)Javad Garousi (17 shared papers)Karl Andersson (14 shared papers)Stefan Ståhl (13 shared papers)Ulrika Rosenström (11 shared papers)
Journals: Scientific Reports (10 papers)Molecular Pharmaceutics (5 papers)International Journal of Oncology (5 papers)Journal of Nuclear Medicine (4 papers)Pharmaceutics (3 papers)
Partner nations: Sweden Russia Netherlands

In The Last Decade

Bogdan Mitran

53 papers receiving 1.3k citations

Peers

Countries citing papers authored by Bogdan Mitran

Since Specialization

Citations

This map shows the geographic impact of Bogdan Mitran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bogdan Mitran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bogdan Mitran more than expected).

Fields of papers citing papers by Bogdan Mitran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bogdan Mitran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bogdan Mitran. The network helps show where Bogdan Mitran may publish in the future.

Co-authors

The 25 scholars most cited alongside Bogdan Mitran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bogdan Mitran Line = papers co-authored together Bogdan Mitran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Effect of Mini-PEG-Based Spacer Length on Binding and Pharmacokinetic Properties of a 68Ga-Labeled NOTA-Conjugated Antagonistic Analog of Bombesin Molecules ·Zohreh Varasteh, Ulrika Rosenström, Irina Velikyan, Bogdan Mitran, Mohamed Altai, Hadis Honarvar, Maria� Rosestedt, Gunnar Lindeberg, Jens Sørensen, Mats Larhed, Vladimir Tolmachev, Anna Orlova	2014	62
2	Affibody-mediated PET imaging of HER3 expression in malignant tumours Scientific Reports ·Maria� Rosestedt, Karl Andersson, Bogdan Mitran, Vladimir Tolmachev, John Löfblom, Anna Orlova, Stefan Ståhl	2015	59
3	The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26 Nuclear Medicine and Biology ·Zohreh Varasteh, Bogdan Mitran, Ulrika Rosenström, Irina Velikyan, Maria� Rosestedt, Gunnar Lindeberg, Jens Christian Hedemann Sørensen, Mats Larhed, Vladimir Tolmachev, Anna Orlova	2014	55
4	Affibody-derived drug conjugates: Potent cytotoxic molecules for treatment of HER2 over-expressing tumors Journal of Controlled Release ·Mohamed Altai, Hao Liu, Haozhong Ding, Bogdan Mitran, Per-Henrik Edqvist, Vladimir Tolmachev, Anna Orlova, Torbjörn Gräslund	2018	54
5	PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules International Journal of Oncology ·Javad Garousi, Karl Andersson, Bogdan Mitran, MARIE-LOUISE PICHL, Stefan Ståhl, Anna Orlova, John Löfblom, Vladimir Tolmachev	2016	51
6	Feasibility of Affibody-Based Bioorthogonal Chemistry–Mediated Radionuclide Pretargeting Journal of Nuclear Medicine ·Mohamed Altai, Anna Perols, Maria Tsourma, Bogdan Mitran, Hadis Honarvar, Marc S. Robillard, Raffaella Rossin, Wolter ten Hoeve, Mark Lubberink, Anna Orlova, Amelie Eriksson Karlström, Vladimir Tolmachev	2015	50
7	Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid–Mediated Pretargeting: In Vivo Proof of Principle Journal of Nuclear Medicine ·Kristina Westerlund, Mohamed Altai, Bogdan Mitran, Mark Konijnenberg, Maryam Oroujeni, Christina Atterby, Marion de Jong, Anna Orlova, Johanna Sofia Margareta Mattsson, Patrick Micke, Amelie Eriksson Karlström, Vladimir Tolmachev	2018	47
8	Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer Cancers ·Bogdan Mitran, Zohreh Varasteh, Ayman Abouzayed, Sara S. Rinne, Emmi Puuvuori, Maria De Rosa, Mats Larhed, Vladimir Tolmachev, Anna Orlova, Ulrika Rosenström	2019	42
9	Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules Molecular Pharmaceutics ·Kristina Westerlund, Hadis Honarvar, Emily Norrström, Joanna Strand, Bogdan Mitran, Anna Orlova, Amelie Eriksson Karlström, Vladimir Tolmachev	2016	40
10	Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties Molecular Pharmaceutics ·Sergey M. Deyev, Anzhelika Vorobyeva, Alexey Schulga, Г. М. Прошкина, Rezan Güler, John Löfblom, Bogdan Mitran, Javad Garousi, Mohamed Altai, Jos Buijs, В. И. Чернов, Anna Orlova, Vladimir Tolmachev	2019	40
11	Selection of optimal chelator improves the contrast of GRPR imaging using bombesin analogue RM26 International Journal of Oncology ·Bogdan Mitran, Zohreh Varasteh, Ram Kumar Selvaraju, Gunnar Lindeberg, Jens Christian Hedemann Sørensen, Mats Larhed, Vladimir Tolmachev, Ulrika Rosenström, Anna Orlova	2016	38
12	Trastuzumab cotreatment improves survival of mice with PC‐3 prostate cancer xenografts treated with the GRPR antagonist ¹⁷⁷Lu‐DOTAGA‐PEG₂‐RM26 International Journal of Cancer ·Bogdan Mitran, Sara S. Rinne, Mark Konijnenberg, Θεοδοσία Μάινα, Berthold A. Nock, Mohamed Altai, Anzhelika Vorobyeva, Mats Larhed, Vladimir Tolmachev, Marion de Jong, Ulrika Rosenström, Anna Orlova	2019	37
13	Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors Contrast Media & Molecular Imaging ·Anzhelika Vorobyeva, Olga Bragina, Mohamed Altai, Bogdan Mitran, Anna Orlova, A. A. Shulga, Г. М. Прошкина, В. И. Чернов, Vladimir Tolmachev, Sergey M. Deyev	2018	34
14	Cyclic versus Noncyclic Chelating Scaffold for ⁸⁹Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression Molecular Pharmaceutics ·Dominik Summer, Javad Garousi, Maryam Oroujeni, Bogdan Mitran, Karl Andersson, Anzhelika Vorobyeva, John Löfblom, Anna Orlova, Vladimir Tolmachev, Clemens Decristoforo	2017	34
15	Radionuclide Tumor Targeting Using ADAPT Scaffold Proteins: Aspects of Label Positioning and Residualizing Properties of the Label Journal of Nuclear Medicine ·Sarah Lindbo, Javad Garousi, Bogdan Mitran, Mohamed Altai, Jos Buijs, Anna Orlova, Sophia Hober, Vladimir Tolmachev	2017	33
16	Comparative Evaluation of Affibody Molecules for Radionuclide Imaging of in Vivo Expression of Carbonic Anhydrase IX Molecular Pharmaceutics ·Javad Garousi, Hadis Honarvar, Karl Andersson, Bogdan Mitran, Anna Orlova, Jos Buijs, John Löfblom, Fredrik Y. Frejd, Vladimir Tolmachev	2016	32
17	High Contrast PET Imaging of GRPR Expression in Prostate Cancer Using Cobalt-Labeled Bombesin Antagonist RM26 Contrast Media & Molecular Imaging ·Bogdan Mitran, Helge Thisgaard, Ulrika Rosenström, Johan Hygum Dam, Mats Larhed, Vladimir Tolmachev, Anna Orlova	2017	31
18	The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule Scientific Reports ·Javad Garousi, Karl Andersson, Johan Hygum Dam, Birgitte Brinkmann Olsen, Bogdan Mitran, Anna Orlova, Jos Buijs, Stefan Ståhl, John Löfblom, Helge Thisgaard, Vladimir Tolmachev	2017	30
19	Comparison of tumor‑targeting properties of directly and indirectly radioiodinated designed ankyrin repeat protein (DARPin) G3 variants for molecular imaging of HER2 International Journal of Oncology ·Anzhelika Vorobyeva, Alexey Sсhulga, Е. В. Коновалова, Rezan G�ler, Bogdan Mitran, Javad Garousi, Sara S. Rinne, John L�fblom, Anna Orlova, Sergey M. Deyev, Vladimir Tolmachev	2019	27
20	Radionuclide imaging of VEGFR2 in glioma vasculature using biparatopic affibody conjugate: proof-of-principle in a murine model Theranostics ·Bogdan Mitran, Rezan Güler, Francis P. Roche, Elin Lindström, Ram Kumar Selvaraju, Filippa Fleetwood, Sara S. Rinne, Lena Claesson‐Welsh, Vladimir Tolmachev, Stefan Ståhl, Anna Orlova, John Löfblom	2018	27

About Bogdan Mitran

Bogdan Mitran is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Genetics and Epidemiology, having authored 55 papers that have together received 1.3k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (40 papers), Monoclonal and Polyclonal Antibodies Research (35 papers), HER2/EGFR in Cancer Research (16 papers), Peptidase Inhibition and Analysis (10 papers), Prostate Cancer Treatment and Research (9 papers), Neuroendocrine Tumor Research Advances (7 papers), Glycosylation and Glycoproteins Research (5 papers) and Medical Imaging Techniques and Applications (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.1k citations), Oncology (688 citations), Pulmonary and Respiratory Medicine (263 citations), Molecular Biology (370 citations) and Biomaterials (57 citations). Bogdan Mitran has collaborated with scholars based in Sweden, Russia and Netherlands. Frequent co-authors include Anna Orlova, Vladimir Tolmachev, John Löfblom, Mohamed Altai, Javad Garousi, Karl Andersson, Stefan Ståhl, Ulrika Rosenström, Anzhelika Vorobyeva and Sara S. Rinne. Their work appears in journals such as Scientific Reports, Molecular Pharmaceutics, International Journal of Oncology, Journal of Nuclear Medicine and Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact